⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycolic Acid SCHEMBL23062835 | 0.90 | OR51E2 (0.37) | — | |
| Glycolic Acid SCHEMBL28818431 | 0.86 | TSHR (0.42) | — | |
| Glycolic Acid SCHEMBL3899680 | 0.84 | — | — | |
| Glycolic Acid SCHEMBL20481333 | 0.84 | — | — | |
| Glycolic Acid SCHEMBL1331333 | 0.83 | — | — | |
| Glycolic Acid SCHEMBL811403 | 0.83 | LMNA (0.50) | — | |
| Glycolic Acid SCHEMBL2518351 | 0.83 | LMNA (0.50) | — | |
| Glycolic Acid SCHEMBL6362687 | 0.83 | — | — | |
| Glycolic Acid SCHEMBL1222 | 0.83 | — | — | |
| Glycolic Acid SCHEMBL11698763 | 0.83 | LMNA (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267114-A1 | ZEIN NANOPARTICLES FOR USE IN HYPERGLYCEMIC CONDITIONS | Universidad de Navarra (ES) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022136393-A1 | ZEIN NANOPARTICLES FOR USE IN HYPERGLYCEMIC CONDITIONS | UNIVERSIDAD DE NAVARRA (ES) | 2022-06-30 | — | — | WO | disclosed |
| US-10555912-B2 | Use of polymeric excipients for lyophilization or freezing of particles | ABRAXIS BIOSCIENCE, LLC (US) | 2020-02-11 | — | — | US | disclosed |
| EP-3077007-B1 | REVERSIBLE PEGYLATION OF NANOCARRIERS | UNIV FREIBURG ALBERT LUDWIGS (DE) | 2019-11-20 | — | — | EP | disclosed |
| EP-3560486-A1 | USE OF POLYMERIC EXCIPIENTS FOR LYOPHILIZATION OR FREEZING OF PARTICLES | Abraxis BioScience, LLC (US) | 2019-10-30 | — | — | EP | disclosed |
| EP-2790675-B1 | USE OF POLYMERIC EXCIPIENTS FOR LYOPHILIZATION OR FREEZING OF PARTICLES | ABRAXIS BIOSCIENCE LLC (US) | 2019-07-03 | — | — | EP | disclosed |
| CN-109564984-A | Electronic device with bank structure | 默克专利有限公司 | 2019-04-02 | — | — | CN | disclosed |
| US-20190054033-A1 | USE OF POLYMERIC EXCIPIENTS FOR LYOPHILIZATION OR FREEZING OF PARTICLES | ABRAXIS BIOSCIENCE, LLC | 2019-02-21 | — | — | US | disclosed |
| US-9585960-B2 | Use of polymeric excipients for lyophilization or freezing of particles | ABRAXIS BIOSCIENCE, LLC (US) | 2017-03-07 | — | — | US | disclosed |
| US-20170035910-A1 | Reversible Pegylation of Nanocarriers | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2017-02-09 | — | — | US | disclosed |
| US-5428101-A | Contains a vinyl polymer having a substituted acylamide group | NIPPON PAINT CO., LTD. (JP) | 1995-06-27 | — | — | US | disclosed |
| EP-0413351-B1 | Aqueous dispersion coating composition | NIPPON PAINT CO LTD (JP) | 1995-05-17 | — | — | EP | disclosed |
| EP-0413352-B1 | Solvent based coating composition | NIPPON PAINT CO LTD (JP) | 1994-12-28 | — | — | EP | disclosed |
| US-5348991-A | N-oxycarbonylacrylamide resin | NIPPON PAINT CO., LTD. (JP) | 1994-09-20 | — | — | US | disclosed |
| EP-0431554-B1 | Cationic electrocoating composition | NIPPON PAINT CO LTD (JP) | 1994-04-06 | — | — | EP | disclosed |
| EP-0431554-A2 | Cationic electrocoating composition | NIPPON PAINT CO., LTD. (JP) | 1991-06-12 | — | — | EP | disclosed |
| EP-0413352-A2 | Solvent based coating composition | Nippon Paint Co., Ltd. (JP) | 1991-02-20 | — | — | EP | disclosed |
| EP-0413351-A2 | Aqueous dispersion coating composition | Nippon Paint Co., Ltd. (JP) | 1991-02-20 | — | — | EP | disclosed |
| CN-1048556-A | CATIONIC LATEX COATING | ROHM & HAAS (US) | 1991-01-16 | — | — | CN | disclosed |
| EP-0252289-A2 | Transesterification catalysts and thermoset coatings | THE GLIDDEN COMPANY (US) | 1988-01-13 | — | — | EP | disclosed |